Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy


REQUITE on Facebook

Report on patient recruitment for REQUITE observational study available!

Across all tumour sites by 30th September 2016, the consortium (including third party sites)
recruited 4,314 patients, representing 81.4% of the overall target.

The report gives an update on patient recruitment for the REQUITE observational study by 30th September 2016. One of the deliverables for Work package 2 (Multi-centre observational study) was to report of patient recruitment on the REQUITE website. To view the full report click here.

Two REQUITE posters at NCRI Cancer Conference!

The NCRI Cancer Conference 2016 took place in Liverpool from 6-9 November. The National Cancer Research Institute (NCRI) is a UK-wide partnership between research funders working together to make faster progress against cancer. The NCRI Cancer Conference  showcases the latest basic, translational and clinical cancer research. It brings researchers together to share ideas and develop collaborations.

Two REQUITE abstracts have been accepted for poster presentation.

REQUITE paper accepted for publication in Radiotherapy and Oncology!

The paper "Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement", D. De Ruysscher, et al., has been accepted for publication in Radiotherapy and Oncology. Radiotherapy & Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology.

Older news




San Antonio Breast Cancer Symposium 2016

The abstract: "The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients" from Dr. Tim Rattay, et al, has been confirmed as poster at the SABCS.

Since 1977, the Symposium’s mission has been to provide state-of-the-art information on breast cancer research. From a one-day regional conference, the Symposium has grown to a five-day program attended by a broad international audience of academic and private researchers and physicians from over 90 countries.

The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

Tuesday, 6 December, 2016 to Saturday, 10 December, 2016
Henry B. Gonzalez Convention Center
200 E. Market Street
Texas 78205 San Antonio
United States